Patient

Diagnosis

(Sex/Ethnicity)

BMT Age (yr)

Eye

CE Age (yr)

Follow-up (mo)

Pre-op BCVA

Most recent BCVA

A

ALD (male/C)

4.1

1

8.5

86.3

20/80

20/20

2

8.6

86.1

20/60

20/25

B

ALL (male/C)

2.6

3

6.0

103.6

20/30

20/20

4

6.0

103.3

20/40

20/20

C

ALL (male/C)

3.1

5

15.4

21.3

20/50

20/20

D

ALL (female/H)

3.5

6

7.1

127.1

20/80

20/20

7

7.2

125.7

20/80

20/15

E

ALL (female/H)

4.8

8

9.9

59.3

20/40

20/30

9

10.0

58.6

20/50

20/30

F

ALL (female/H)

5.4

10

8.0

67.4

20/250

20/60

G

ALL (female/G)

5.8

11

11.7

68.4

20/200

20/60

12

11.4

71.7

20/100

20/20

H

ALL (female/H)

6.4

13

11.0

6.9

20/80

20/40

14

11.0

6.6

20/60

20/40

I

AML (male/C)

3.3

15

13.0

1.2

20/150

20/30

16

13.0

1.0

20/300

20/40

J

AML (male/AA)

3.6

17

7.9

107.8

2 ft 200

CF 1 ft

18

7.9

107.1

2 ft 200

CF 1 ft

K

AML (male/C)

3.9

19

7.9

11.9

20/60

20/30

20

7.7

14.0

20/70

20/30

L

Fanconi (female/H)

6.3

21

9.5

24.8

20/150

20/30

22

9.5

24.5

20/70

20/30

M

JML (male/C)

0.5

23

9.4

5.3

20/80

20/80

24

9.4

4.6

20/40

20/50

N

MDS (male/H)

2.0

23

7.0

130.1

20/50

20/25

26

6.9

131.3

20/60

20/30

O

MDS (female/C)

4.1

27

7.1

23.1

20/50

20/30

28

7.1

22.9

20/50

20/30